Skip to main content
Erschienen in: International Urology and Nephrology 1/2008

01.03.2008 | Original Article

Semi-rigid ureterorenoscopy in children without ureteral dilatation

verfasst von: Abdullah Gedik, Seyfettin Orgen, Ali Ferruh Akay, Hayrettin Sahin, Mehmet Kamuran Bircan

Erschienen in: International Urology and Nephrology | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We aimed to retrospectively review the efficiency of ureterorenoscopy (URS) applied without ureteral dilatation for evaluating pediatric ureteral pathologies.

Methods

The files of pediatric patients hospitalized in our clinic between January 2000 and June 2006 due to ureteral stone disease were reviewed and evaluated retrospectively. The ages, medical histories, physical examination results, preoperative routine blood and urinary tests, and culture results were recorded. Ureteral orifice dilatation was not needed in any of the patients. Due to the risk of mucosal trauma and edema development in the ureteral orifice and intramural ureter, 3F and 4F catheters were applied in all patients following the ureterenoscopy. These catheters were removed 24 h after the procedure.

Results

The files of 54 pediatric patients with a mean age of 8.5 years (range 1–16 years) were evaluated retrospectively. While diagnostic URS was applied in 12 (22.2%) of the patients, ureteral calculi were determined in 42 (77.8%) patients and the stones were fragmented by pneumatic lithotripter. Twenty-five of the stones were localized in the lower ureter, 16 in the mid-ureter, and 3 in upper ureter. The mean stone size was found to be 7.1 mm (range 4–12). None of the stones migrated to the proximal region. In 2 patients open ureterolithotomy was applied; stones were localized in the upper ureter in both of these patients.

Conclusions

Ureterorenoscopy can be successfully and safely applied without the need for ureteral dilatation in ureteral pathologies of children.
Literatur
1.
Zurück zum Zitat Busaidy SS, Prem AR, Medhat M (1997) Pediatric ureteroscopy for ureteric calculi: a 4-year experience. Br J Urol 80:797–801PubMed Busaidy SS, Prem AR, Medhat M (1997) Pediatric ureteroscopy for ureteric calculi: a 4-year experience. Br J Urol 80:797–801PubMed
2.
Zurück zum Zitat Choong S, Whitfield H, Duffy P, Kellett M, Cuckow P, Van’t Hoff W, Corry D (2000) The management of paediatric urolithiasis. BJU Int 86(7):857–860PubMedCrossRef Choong S, Whitfield H, Duffy P, Kellett M, Cuckow P, Van’t Hoff W, Corry D (2000) The management of paediatric urolithiasis. BJU Int 86(7):857–860PubMedCrossRef
3.
Zurück zum Zitat Tan MO, Karaoglan U, Sozen S, Biri H, Deniz N, Bozkirli I (2006) Minimally invasive treatment of ureteral calculi in children. Urol Res 34:381–387PubMedCrossRef Tan MO, Karaoglan U, Sozen S, Biri H, Deniz N, Bozkirli I (2006) Minimally invasive treatment of ureteral calculi in children. Urol Res 34:381–387PubMedCrossRef
4.
Zurück zum Zitat Lahme S (2006) Shockwave lithotripsy and endourological stone treatment in children. Urol Res 34(2):112–117PubMedCrossRef Lahme S (2006) Shockwave lithotripsy and endourological stone treatment in children. Urol Res 34(2):112–117PubMedCrossRef
5.
Zurück zum Zitat Hill DE, Segura JW, Patterson DE et al (1990) Ureteroscopy in children. J Urol 144:481–483PubMed Hill DE, Segura JW, Patterson DE et al (1990) Ureteroscopy in children. J Urol 144:481–483PubMed
6.
Zurück zum Zitat Defoor W, Dharamsi N, Smith P et al. (2005) Use of mobile extracorporeal shock wave lithotripter: experience in a pediatric institution. Urology 65:778–781PubMedCrossRef Defoor W, Dharamsi N, Smith P et al. (2005) Use of mobile extracorporeal shock wave lithotripter: experience in a pediatric institution. Urology 65:778–781PubMedCrossRef
7.
Zurück zum Zitat Minevich E, Defoor W, Reddy P et al (2005) Ureteroscopy is safe and effective in prepubertal children. J Urol 174:276–279; discussion 279PubMedCrossRef Minevich E, Defoor W, Reddy P et al (2005) Ureteroscopy is safe and effective in prepubertal children. J Urol 174:276–279; discussion 279PubMedCrossRef
9.
Zurück zum Zitat Borgmann V, Nagel R (1982) Urolithiasis in childhood: a study of 181 cases. Urol Int 37:194–204CrossRef Borgmann V, Nagel R (1982) Urolithiasis in childhood: a study of 181 cases. Urol Int 37:194–204CrossRef
10.
Zurück zum Zitat Shroff S, Watson GM (1995) Experience with ureteroscopy in children. Br J Urol 75(3):395–400PubMed Shroff S, Watson GM (1995) Experience with ureteroscopy in children. Br J Urol 75(3):395–400PubMed
11.
Zurück zum Zitat Jones BJ, Ryan PC, Lyons O, Grainger R, McDermott TE, Butler MR (1990) Use of the double pigtail stent in stone retrieval following unsuccessful ureteroscopy. Br J Urol 66(3):254–256PubMedCrossRef Jones BJ, Ryan PC, Lyons O, Grainger R, McDermott TE, Butler MR (1990) Use of the double pigtail stent in stone retrieval following unsuccessful ureteroscopy. Br J Urol 66(3):254–256PubMedCrossRef
12.
Zurück zum Zitat El-Assmy A, Hafez AT, Eraky I et al (2006) Safety and outcome of rigid ureteroscopy for management of ureteral calculi in children. J Endourol 20(4):252–255PubMedCrossRef El-Assmy A, Hafez AT, Eraky I et al (2006) Safety and outcome of rigid ureteroscopy for management of ureteral calculi in children. J Endourol 20(4):252–255PubMedCrossRef
13.
Zurück zum Zitat Hubert KC, Palmer JS (2005) Passive dilation by ureteral stenting before ureteroscopy: eliminating the need for active dilation. J Urol 174(3):1079–1080PubMedCrossRef Hubert KC, Palmer JS (2005) Passive dilation by ureteral stenting before ureteroscopy: eliminating the need for active dilation. J Urol 174(3):1079–1080PubMedCrossRef
14.
Zurück zum Zitat Soygur T, Zumrutbas AE, Gulpinar O, Suer E, Arikan N (2005) Hydrodilation of the ureteral orifice in children renders ureteroscopic access possible without any further active dilation. J Urol 176(1):285–287CrossRef Soygur T, Zumrutbas AE, Gulpinar O, Suer E, Arikan N (2005) Hydrodilation of the ureteral orifice in children renders ureteroscopic access possible without any further active dilation. J Urol 176(1):285–287CrossRef
15.
Zurück zum Zitat Kurzrock EA, Huffman JL, Hardy BE, Fugelso P (1996) Endoscopic treatment of pediatric urolithiasis. J Pediatr Surg 31(10):1413–1416PubMedCrossRef Kurzrock EA, Huffman JL, Hardy BE, Fugelso P (1996) Endoscopic treatment of pediatric urolithiasis. J Pediatr Surg 31(10):1413–1416PubMedCrossRef
16.
Zurück zum Zitat Tana AH, Al-Omara M, Denstedt JD, Razvia H (2005) Ureteroscopy for pediatric urolithiasis: an evolving first-line therapy. Urology 65(1):153–156CrossRef Tana AH, Al-Omara M, Denstedt JD, Razvia H (2005) Ureteroscopy for pediatric urolithiasis: an evolving first-line therapy. Urology 65(1):153–156CrossRef
Metadaten
Titel
Semi-rigid ureterorenoscopy in children without ureteral dilatation
verfasst von
Abdullah Gedik
Seyfettin Orgen
Ali Ferruh Akay
Hayrettin Sahin
Mehmet Kamuran Bircan
Publikationsdatum
01.03.2008
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 1/2008
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-007-9235-5

Weitere Artikel der Ausgabe 1/2008

International Urology and Nephrology 1/2008 Zur Ausgabe

Acknowledgments

Reviewers 2007

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.